Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,118
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,793
Class I recallsReasonable probability of serious health consequences
24,343
Class II recallsTemporary or medically reversible health consequences
2,887
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,072 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,343
Class I9,793
Class III2,887
Not Yet Classified1
Download CSV
Recalls by class
ClassRecalls
Class II24,343
Class I9,793
Class III2,887
Not Yet Classified1

Showing 9,681–9,700 of 17,327 recalls

FDA Recall Terminated Historical recordClass II

LIPO-DEN PLUS Injectable-30 mL MDV Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532

by Coastal Meds, LLC.

Reason
Presence of Particulate matter. Recall due to presence of unknown particulate matter.
Published
May 2, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

LIPO-DEN EXTREME Injectable-30 mL MDV Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532

by Coastal Meds, LLC.

Reason
Presence of Particulate matter. Recall due to presence of unknown particulate matter.
Published
May 2, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

LIPO-DEN Injectable-30 mL MDV Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532

by Coastal Meds, LLC.

Reason
Presence of Particulate matter. Recall due to presence of unknown particulate matter.
Published
May 2, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

LIPO-B Injectable-30 mL MDV Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532

by Coastal Meds, LLC.

Reason
Presence of Particulate matter. Recall due to presence of unknown particulate matter.
Published
May 2, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

HYDROXOCOBALAMIN Injectable-30 mL MDV. Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532

by Coastal Meds, LLC.

Reason
Presence of Particulate matter. Recall due to presence of unknown particulate matter.
Published
May 2, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

ADENO-PLEX Injectable-30 mL MDV. Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532

by Coastal Meds, LLC.

Reason
Presence of Particulate matter. Recall due to presence of unknown particulate matter.
Published
May 2, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

CYANOCOBALAMIN Injectable-30 mL MDV. Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532

by Coastal Meds, LLC.

Reason
Presence of Particulate matter. Recall due to presence of unknown particulate matter.
Published
May 2, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Diltiazem HCl Extended-Release Capsules, USP 240 mg, 100-count bottles, Rx Only, Mfg. By: Par Pharmaceutical One Ram Ridge Rd Chestnut Ridge, NY 10977. NDC: 63739-016-10

by Mckesson Packaging Services

Reason
Failed Dissolution Specifications. High dissolution results were obtained during stability testing.
Published
May 2, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Diltiazem CD (Diltiazem Hydrochloride Extended-Release Capsules, USP) 180 mg, 100-count bottles, Rx Only Mfg. By: Actavis 60 Columbia Rd., Bldg. B Morristown, NJ 07960. NDC 63739-284-10

by Mckesson Packaging Services

Reason
Failed Dissolution Specifications. High dissolution results were obtained during stability testing.
Published
May 2, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Diltiazem HCl Extended-Release Capsules, USP 120 mg, 100-count bottles, Rx only, Mfg. By: Par Pharmaceutical One Ram Ridge Rd Chestnut Ridge, NY 10977. NDC: 63739-014-10

by Mckesson Packaging Services

Reason
Failed Dissolution Specifications. High dissolution results were obtained during stability testing.
Published
May 2, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

NEOstigmine Methylsulfate (1 mg/mL) 3mg per 3mL. 3mL Single Dose Syringe. Premier Pharmacy Labs. 8265 Commercial Way Weeki Wachee, FL 34613 NDC 69623-234-14.

by Premier Pharmacy Labs Inc

Reason
Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of subsequent unreleased product lots due to interaction between the product syringe and tamper evident container closure, which may result in the potential introduction of microorganisms into the products.
Published
May 2, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Hydromorphone HCl 1 mg/mL PF INJ. 1mL in a 3mL Sterile Single-Dose Syringe. 8265 Commercial Way Weeki Wachee, FL 34613 NDC 69623-249-10

by Premier Pharmacy Labs Inc

Reason
Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of subsequent unreleased product lots due to interaction between the product syringe and tamper evident container closure, which may result in the potential introduction of microorganisms into the products.
Published
May 2, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Morphine Sulfate 4 mg/mL PF Injection. 1 mL in a 3ml Sterile Single-Dose Syringe. 8265 Commerical Way Weeki Wachee, FL 34613. NDC 69623-127-10

by Premier Pharmacy Labs Inc

Reason
Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of subsequent unreleased product lots due to interaction between the product syringe and tamper evident container closure, which may result in the potential introduction of microorganisms into the products.
Published
May 2, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Morphine Sulfate 2 mg/mL PF Injection. 1 mL in a 3ml Sterile Single-Dose Syringe. 8265 Commerical Way Weeki Wachee, FL 34613. NDC 69623-129-10

by Premier Pharmacy Labs Inc

Reason
Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of subsequent unreleased product lots due to interaction between the product syringe and tamper evident container closure, which may result in the potential introduction of microorganisms into the products.
Published
May 2, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

All Alka-Seltzer Plus¿ packages with a full front panel instant Redeemable Coupon (IRC) affixed to the individual carton. The recalled products can be identified by checking the Bayer logo located on the lower left corner of the front of the carton. If the logo has an orange or green background, the product is included in the recall.

by Bayer HealthCare Pharmaceuticals, Inc.

Reason
Labeling: Label Mix-Up: Bayer is recalling all Alka-Seltzer Plus packages, with a green or orange Bayer logo located on the lower left corner of the front of the carton, because the ingredients on the front sticker may not match the actual product in the carton.
Published
May 2, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Ibuprofen Caplets USP 200 mg, a) 50 caplets (NDC 53943-292-15), b) 100 caplets (NDC 53493-292-12), and c) 500 caplets (NDC 53493-292-14) bottles, Distributed by Drug Mart, Food Fair, Medina, Ohio 44256, Manufactured by: Marksans Pharma, Ltd., Verna, Goa-403 722, India

by Time-Cap Laboratories, Inc.

Reason
CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.
Published
May 2, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Ibuprofen Caplets USP 200 mg, a) 50 caplets (NDC 49483-600-05), b) 100 caplets (NDC 49483-600-01), c) 500 caplets (NDC 49483-600-50), and d) BULK (NDC 49483-600-00) bottles, Rx, Manufactured for: Time Cap labs, Inc., Farmingdale, NY 11735, Manufactured by: Marksans Pharma, Ltd., Verna, Goa-403 722, India

by Time-Cap Laboratories, Inc.

Reason
CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.
Published
May 2, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Ibuprofen Tablets USP 800 mg, a) 100 tablet (NDC 42582-113-10) and b) 500 tablet (NDC 42582-113-18) bottles, Rx, Distributed by; Bi-Coastal Pharma International, Shrewsbury, NJ, Manufactured by: Marksans Pharma, Ltd., Verna, Goa-403 722, India

by Time-Cap Laboratories, Inc.

Reason
CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.
Published
May 2, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Ibuprofen Tablets USP 800 mg, a) 100 tablet (NDC 49483-604-01) and b) 500 tablet (NDC 49483-604-50) bottles, Rx, Manufactured for: Time Cap labs, Inc., Farmingdale, NY 11735, USA, Manufactured by: Marksans Pharma, Ltd., Verna, Goa-403 722, India

by Time-Cap Laboratories, Inc.

Reason
CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.
Published
May 2, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Ibuprofen Tablets USP 600 mg, a) 100 tablet (NDC 42582-112-01), b) 500 tablet bottles (NDC 42582-112-18), Rx, Distributed by Drug Mart, Food Fair, Medina, Ohio 44256

by Time-Cap Laboratories, Inc.

Reason
CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.
Published
May 2, 2018
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.